Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ken Marumo

Showing results (1-10 of 44) with videos related to

Pageof 5
Sort By:
Nihon Rinsho. Japanese Journal of Clinical Medicine|August 9, 2002
[Aging and erectile dysfunction]Ken Marumo, Masaru Murai
International Journal of Urology : Official Journal of the Japanese Urological Association|October 29, 2004
Biochemical modulation of 5-fluorouracil with interferon alpha/beta and gamma on murine renal cell carcinomaTaketsugu Ishii, Ken Marumo
Nihon Rinsho. Japanese Journal of Clinical Medicine|August 9, 2002
[Analysis on risk factors of erectile dysfunction]Ken Marumo, Masaru Murai
Nihon Rinsho. Japanese Journal of Clinical Medicine|August 9, 2002
[Penile prosthesis]Ken Marumo, Masaru Murai
International Journal of Urology : Official Journal of the Japanese Urological Association|May 7, 2009
Elevated serum IgG4 may predict sensitivity to steroid therapy in retroperitoneal fibrosisKen Marumo, Satoshi Tatsuno, Kensho Noto
Clinical Calcium|June 28, 2016
[Treatment of osteoporosis in hypogonadal men]Ken Marumo, Kenichi Hata, Jun Hagiuda
Kidney International|February 19, 2002
STAT3, but not ERKs, mediates the IL-6-induced proliferation of renal cancer cells, ACHN and 769PAkio Horiguchi, Mototsugu Oya, Ken Marumo, et al.
Nihon Hinyokika Gakkai Zasshi. the Japanese Journal of Urology|December 24, 2010
[Adenocarcinoma of the rete testis. A case report]Jun Hagiuda, Mayuko Matsumoto, Yasumasa Hanawa, et al.
The Journal of Urology|January 25, 2003
Elevated Akt activation and its impact on clinicopathological features of renal cell carcinomaAkio Horiguchi, Mototsugu Oya, Atsushi Uchida, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|July 10, 2004
Dexamethasone and interleukin-2 combination therapy for advanced renal cell carcinoma in a patient with paraneoplastic inflammatory syndromeToshiaki Shinojima, Mototsugu Oya, Hidaka Kohno, et al.
Pageof 5

Showing results (1-10 of 44) with videos related to

Sort By:
Pageof 5
Nihon Rinsho. Japanese Journal of Clinical Medicine|August 9, 2002
[Aging and erectile dysfunction]Ken Marumo, Masaru Murai
International Journal of Urology : Official Journal of the Japanese Urological Association|October 29, 2004
Biochemical modulation of 5-fluorouracil with interferon alpha/beta and gamma on murine renal cell carcinomaTaketsugu Ishii, Ken Marumo
Nihon Rinsho. Japanese Journal of Clinical Medicine|August 9, 2002
[Analysis on risk factors of erectile dysfunction]Ken Marumo, Masaru Murai
Nihon Rinsho. Japanese Journal of Clinical Medicine|August 9, 2002
[Penile prosthesis]Ken Marumo, Masaru Murai
International Journal of Urology : Official Journal of the Japanese Urological Association|May 7, 2009
Elevated serum IgG4 may predict sensitivity to steroid therapy in retroperitoneal fibrosisKen Marumo, Satoshi Tatsuno, Kensho Noto
Clinical Calcium|June 28, 2016
[Treatment of osteoporosis in hypogonadal men]Ken Marumo, Kenichi Hata, Jun Hagiuda
Kidney International|February 19, 2002
STAT3, but not ERKs, mediates the IL-6-induced proliferation of renal cancer cells, ACHN and 769PAkio Horiguchi, Mototsugu Oya, Ken Marumo, et al.
Nihon Hinyokika Gakkai Zasshi. the Japanese Journal of Urology|December 24, 2010
[Adenocarcinoma of the rete testis. A case report]Jun Hagiuda, Mayuko Matsumoto, Yasumasa Hanawa, et al.
The Journal of Urology|January 25, 2003
Elevated Akt activation and its impact on clinicopathological features of renal cell carcinomaAkio Horiguchi, Mototsugu Oya, Atsushi Uchida, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|July 10, 2004
Dexamethasone and interleukin-2 combination therapy for advanced renal cell carcinoma in a patient with paraneoplastic inflammatory syndromeToshiaki Shinojima, Mototsugu Oya, Hidaka Kohno, et al.
Pageof 5